These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1827284)

  • 1. Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.
    Archimbaud E; Guyotat D; Maupas J; Ploton C; Nageotte A; Devaux Y; Thomas X; Fleurette J; Fiere D
    Eur J Cancer; 1991; 27(2):174-8. PubMed ID: 1827284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].
    Thomas X; Troncy J; Belhabri A; Thiebaut A; Bouheddou N; Michallet M; Fleurette J; Pivot C; Fiere D; Archimbaud E
    Presse Med; 2000 Oct; 29(32):1745-51. PubMed ID: 11098268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
    Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
    Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
    Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM
    J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
    Kelsey SM; Shaw E; Newland AC
    J Chemother; 1992 Apr; 4(2):107-13. PubMed ID: 1629747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
    Chow AW; Jewesson PJ; Kureishi A; Phillips GL
    Eur J Haematol Suppl; 1993; 54():18-24. PubMed ID: 8365461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients.
    van de Leur JJ; Vollaard EJ; Janssen AJ; Dofferhoff AS
    Antimicrob Agents Chemother; 1995 May; 39(5):1182-4. PubMed ID: 7625811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
    D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
    Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
    Kattan J; Droz JP; Ribrag V; Azab M; Boutan-Laroze A; Andremont A
    Eur J Cancer; 1992; 28A(4-5):867-70. PubMed ID: 1524911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
    D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
    J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of infections in neutropenic patients with pefloxacin.
    Meunier F
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():69-73. PubMed ID: 2258354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention using pefloxacin of infections in cancer patients with granulocytopenia].
    Leleux A; Snoeck R; Gerain J; Van der Auwera P; Daneau D; Meunier F
    Presse Med; 1989 Jan 7-14; 18(1):21-4. PubMed ID: 2521710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
    Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA
    Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():173-80. PubMed ID: 2258346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
    Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
    Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
    Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G
    J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.
    Lamy T; Michelet C; Dauriac C; Grulois I; Donio PY; Le Prisé PY
    Acta Haematol; 1993; 90(3):109-13. PubMed ID: 8291367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of oral vancomycin in neutropenic patients.
    Guyotat D; Plonton C; Fiere D
    Prog Clin Biol Res; 1985; 181():263-5. PubMed ID: 3895236
    [No Abstract]   [Full Text] [Related]  

  • 20. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Nakao SL; Gale RP; Champlin RE
    Am J Med; 1986 May; 80(5):884-90. PubMed ID: 3010716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.